IGFBP3 and lung carcinoma: Previously, we found that IGFBP‐3 binds HA via amino acid residues 215–232 in the C‐terminal region of the protein (215‐KKGFYKKKQCRPSKGRKR‐232), blocking HA interactions with CD44 and reducing viability of A549 human lung cancer cells [48].